File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Antifungal drug usage in haematologic patients during a 4-year period in an Asian university teaching hospital

TitleAntifungal drug usage in haematologic patients during a 4-year period in an Asian university teaching hospital
Authors
KeywordsAntifungal drug
Leukaemia
Prophylaxis
Bone marrow transplantation
Issue Date2013
Citation
Internal Medicine Journal, 2013, v. 43, n. 5, p. 541-546 How to Cite?
AbstractBackground: Invasive fungal disease (IFD) is an important problem complicating the therapy of haematologic patients. Aim: This study aimed to provide data on the epidemiology of IFD in an Asian teaching hospital, as well as the prescription practice of antifungal drugs. Method: We conducted a retrospective review of 275 haematologic patients who were prescribed antifungal drugs in a 4-year period (2007-2010), of whom 130 (47%) had undergone haematopoietic stem cell transplantation. Results: Antifungal prophylaxis with either fluconazole or itraconazole was given in 214 patients (78%). There were 414 prescriptions of antifungal drugs (including liposomal amphotericin B, voriconazole, caspofungin, micafungin, anidulafungin), of which 361 prescriptions were empirical. There were 14 patients with proven IFD, 11 of whom had breakthrough infection while on itraconazole prophylaxis. Interestingly, seven of these cases were due to infection by itraconazole-sensitive candida. Conclusion: These results provide important epidemiologic data necessary for the formulation of strategies for prevention and treatment of IFD in Asian patients. © 2012 Royal Australasian College of Physicians.
Persistent Identifierhttp://hdl.handle.net/10722/200133
ISSN
2015 Impact Factor: 1.526
2015 SCImago Journal Rankings: 0.616
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorChan, Thomas S Y-
dc.contributor.authorHwang, Yuyan-
dc.contributor.authorGill, Harinder-
dc.contributor.authorCheung, Winnie W W-
dc.contributor.authorTse, Eric-
dc.contributor.authorLeung, Anska Y H-
dc.contributor.authorChim, James C S-
dc.contributor.authorLie, Albert-
dc.contributor.authorKwong, Yok Lam-
dc.date.accessioned2014-07-26T23:11:10Z-
dc.date.available2014-07-26T23:11:10Z-
dc.date.issued2013-
dc.identifier.citationInternal Medicine Journal, 2013, v. 43, n. 5, p. 541-546-
dc.identifier.issn1444-0903-
dc.identifier.urihttp://hdl.handle.net/10722/200133-
dc.description.abstractBackground: Invasive fungal disease (IFD) is an important problem complicating the therapy of haematologic patients. Aim: This study aimed to provide data on the epidemiology of IFD in an Asian teaching hospital, as well as the prescription practice of antifungal drugs. Method: We conducted a retrospective review of 275 haematologic patients who were prescribed antifungal drugs in a 4-year period (2007-2010), of whom 130 (47%) had undergone haematopoietic stem cell transplantation. Results: Antifungal prophylaxis with either fluconazole or itraconazole was given in 214 patients (78%). There were 414 prescriptions of antifungal drugs (including liposomal amphotericin B, voriconazole, caspofungin, micafungin, anidulafungin), of which 361 prescriptions were empirical. There were 14 patients with proven IFD, 11 of whom had breakthrough infection while on itraconazole prophylaxis. Interestingly, seven of these cases were due to infection by itraconazole-sensitive candida. Conclusion: These results provide important epidemiologic data necessary for the formulation of strategies for prevention and treatment of IFD in Asian patients. © 2012 Royal Australasian College of Physicians.-
dc.languageeng-
dc.relation.ispartofInternal Medicine Journal-
dc.subjectAntifungal drug-
dc.subjectLeukaemia-
dc.subjectProphylaxis-
dc.subjectBone marrow transplantation-
dc.titleAntifungal drug usage in haematologic patients during a 4-year period in an Asian university teaching hospital-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1111/imj.12064-
dc.identifier.pmid23279203-
dc.identifier.scopuseid_2-s2.0-84877913985-
dc.identifier.hkuros219157-
dc.identifier.hkuros213802-
dc.identifier.volume43-
dc.identifier.issue5-
dc.identifier.spage541-
dc.identifier.epage546-
dc.identifier.eissn1445-5994-
dc.identifier.isiWOS:000319125000011-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats